Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis
Authors:
Top Cited Papers
Open Access
- 23 December 2024
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 22 (1) , 1-17
Abstract
Helicobacter pylori infection causes gastritis, peptic ulcers, and gastric cancer. The infection is typically acquired in childhood and persists throughout life. The major impediment to successful therapy is antibiotic resistance. This systematic review and meta-analysis aimed to comprehensively assess the global prevalence of antibiotic resistance in pediatric H. pylori infection. We performed a systematic search of publication databases that assessed H. pylori resistance rates to clarithromycin, metronidazole, levofloxacin, amoxicillin, and tetracycline in children. The WHO region classification was used to group pooled primary and secondary resistance estimates along with 95% confidence interval (CI). H. pylori antibiotic resistance rates were retrieved and combined with odds ratios (95% CI) to investigate the global prevalence and temporal trends. Subgroup analysis of the prevalence of antibiotic resistance was conducted by country, age groups, and susceptibility testing methods. Among 1417 records obtained initially, 152 studies were selected for eligibility assessment after applying exclusion criteria in multiple steps. Ultimately, 63 studies involving 15,953 individuals were included comprising data from 28 countries in 5 WHO regions. The primary resistance rates were metronidazole 35.3% (5482/15,529, 95% CI: 28.7–42.6), clarithromycin 32.6% (5071/15,555, 95% CI: 27.7–37.9), tetracycline 2.1% (148/7033, 95% CI: 1.3–3.6), levofloxacin 13.2% (1091/8271, 95% CI: 9.3–18.4), and amoxicillin 4.8% (495/10305, 95% CI: 2.5–8.8). Raising antibiotic resistance was detected in most WHO regions. The escalating trend of H. pylori antibiotic resistance in children warrants urgent attention globally. National and regional surveillance networks are required for antibiotic stewardship in children infected with H. pylori.Keywords
Funding Information
- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran (RIGLD 1128)
This publication has 108 references indexed in Scilit:
- Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023)Journal of Pediatric Gastroenterology and Nutrition, 2024
- Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, ChinaEuropean Journal of Pediatrics, 2022
- Helicobacter pylori treatment: antibiotics or probioticsApplied Microbiology and Biotechnology, 2017
- The Hartung‐Knapp modification for random‐effects meta‐analysis: A useful refinement but are there any residual concerns?Statistics in Medicine, 2017
- Antibiotic resistance of Helicobacter pylori in pediatric patients — 10 years’ experienceEuropean Journal of Pediatrics, 2012
- The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographicsJournal of Infection and Chemotherapy, 2012
- Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse dataStatistics in Medicine, 2010
- Outlier and influence diagnostics for meta-analysisResearch Synthesis Methods, 2010
- Primary resistance in Helicobacter pylori isolated in children from IranJournal of Infection and Chemotherapy, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002